Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for January 23rd

Read MoreHide Full Article

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 23rd:

BioTelemetry, Inc. (BEAT - Free Report) : This fashion and lifestyle products retailer has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 25% over the last 60 days.

BioTelemetry, Inc. Price and Consensus

BioTelemetry’s shares gained 5.2% over the last one month more than S&P 500’s gain of 12.7%. The company possesses a Momentum Score of B.

BioTelemetry, Inc. Price

ABIOMED, Inc. : This developer and seller of medical devices has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.

ABIOMED, Inc. Price and Consensus

ABIOMED’s shares gained 9.3% over the last one month. The company possesses a Momentum Score of A.

ABIOMED, Inc. Price

AC Immune SA (ACIU - Free Report) : This clinical stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 50.6% over the last 60 days.

AC Immune SA Price and Consensus

AC Immune’s shares gained 12.7% over the last one month. The company possesses a Momentum Score of B.

AC Immune SA Price

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Zacks' Top 10 Stocks for 2019

In addition to the stocks discussed above, wouldn't you like to know about our 10 finest buy-and-holds for the year?

From more than 4,000 companies covered by the Zacks Rank, these 10 were picked by a process that consistently beats the market. Even during 2018 while the market dropped -5.2%, our Top 10s were up well into double-digits. And during bullish 2012 – 2017, they soared far above the market's +126.3%, reaching +181.9%.

This year, the portfolio features a player that thrives on volatility, an AI comer, and a dynamic tech company that helps doctors deliver better patient outcomes at lower costs.

See Stocks Today >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


HeartBeam, Inc. (BEAT) - free report >>

AC Immune (ACIU) - free report >>

Published in